Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


David Filmore

Executive Editor

Rochester, NY
David Filmore has been covering the health care sector as a writer and editor for 16 years. He specializes in devices and diagnostics, particularly focusing on the regulatory and reimbursement dynamics that impact a company’s ability to succeed in the marketplace. Originally trained as a scientist, Dave enjoys dissecting technical topics to reach a core understanding. As a writer and editor, he relishes communicating that understanding, important context and key takeaways for practical use by the reader. Dave has led operations or served on the staff of “The Gray Sheet” for more than a decade, and now oversees Regulatory and Policy content for the new Medtech Insight. Previously, he was an editor with the American Chemical Society, producing content for professionals in the pharmaceutical industry and analytical instrumentation space. He has also worked in the pharma industry, and has a degree in chemistry. Dave lives with his wife and two kids in Rochester, NY.
Set Alert for Articles By David Filmore

Latest From David Filmore

Global Device Approvals, Weekly Snapshot: March 5-11, 2018

A snapshot of global medical device and diagnostics approvals recorded in Medtech Insight's Approvals Tracker during the past week.

Approvals Innovation

Device Week, March 9, 2018 – US Policy Updates: CMS, FTC, FDA, Supreme Court

On this week's podcast, we discuss US medtech policy developments from the Centers for Medicare and Medicaid Services, the Federal Trade Commission, FDA and the Supreme Court.

Policy Regulation

Global Device Approvals: Weekly Snapshot

A snapshot of global medical device and diagnostics approvals recorded in Medtech Insight's Approvals Tracker during the past week.

Approvals Innovation

US Regulatory Reads, February 2018: Funding, Digital Health And Program Alignment

While the overall FY 2019 Trump administration budget request submitted last month was widely criticized, the high numbers slated for US FDA in the document attracted positive attention in the life-sciences space, and among Medtech Insight readers. Also popular among US regulatory and policy content last month: coverage of a digital-health gathering, program alignment insights and stories on FDA restructuring, federal enforcement and adverse events trends.

Regulation Policy

Device Week, Feb. 9, 2018 – Last Night In Congress, And Digital-Health Discourse

On this week's podcast, we discuss US Congress' last-minute budget deal that included several Medicare provisions relevant to the medtech sector. And we talk about US FDA's recent two-day workshop on its Pre-Cert Pilot Program for digital health.
Device Week Policy

US Regulatory Reads, January 2018: Medicare, MDSAP And What's Ahead

Medicare news in diabetes, US FDA's horizon, and a view on the Medical Device Single Audit Program. The most popular US regulatory and policy stories in January addressed these topics and more.

Regulation FDA
See All